chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had horrible symptoms for about 5 days. Unsure which vaccine did it to me. Soreness in both arms, but very severe in Right arm (received a total of 5 vaccines). Unable to lift my arm more than 1 or 2 inches. On day 4, my arm had swelling, significant redness and hot to the touch. The area was about 5 cm x 3 cm. Did not go down with TYLENOL or BENADRYL. Other symptoms were extreme fatigue (slept 15 hours one night) and extreme chills. I went to my doctor about another problem while this was going on and my temperature was only 96.2 degrees.
had congestion-cough, sinuses congested sx started 1wk later; dx bronchitis-ATB, antihistimines;
Severe pain Shoulders to hands, stiffness, loss of strength. Same symptoms hips to feet. TX with ibuprofen and acetaminophen. Would get better during day and return at night. Two and a half months later diagnosed as polymyalgia rheumatica and treated with prednisone.
Severe hives itching on buttocks post vaccine day 4,5,6  Petichea noted on buttocks. Spider veins on r buttocks.
This case was reported by a nurse via call center representative and described the occurrence of nerve pain in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced nerve pain and burning sensation. The patient was treated with non-drug therapy (Heat Therapy) and analgesic, nos. On an unknown date, the outcome of the nerve pain and burning sensation were unknown. It was unknown if the reporter considered the nerve pain and burning sensation to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured adult as per vaccine indication. The reporter asked if there were any side effects with nerve pain without a rash lasted for approximately 3 months. The patient also had a strong burning sensation. The patient got relieved with heat and mild pain medication.
This spontaneous report was received from a nurse practitioner via a company representative and refers to a female patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date in the summer (year unspecified), the patient was vaccinated with the first dose of GARDASIL (exact dose, lot # and expiration date were not reported) intramuscularly. On an unknown date (reported as sometime after the vaccination), the patient developed seizure like problems. the patient did not return to the doctor's office but, on an unknown date, she had an magnetic resonance imaging (MRI) at another physician's office, which showed other potential causes for the seizures. No product quality complaint (PQC) was reported. the outcome of seizure like problems was unknown. the relatedness between the event and GARDASIL was not reported. Upon internal review, the event of seizure like problems was considered to be medically significant. Additional information is not expected, the reporter did not wish to be contacted.
itching at Flublok injection site; Initial information received on 28-Oct-2020 regarding an unsolicited valid non-serious case received from the other health professional via sales specialist at call center as an inquiry (reference number: US-SANOFI-00336397).  This case involved a 54-year old female patient who experienced itching at Flublok injection site (Injection site pruritus), after receiving INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (FLUBLOK QIV).  Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On 21-Oct-2020, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot number: UJ509AA, expiry date: 10-May-2021) via unknown route in the left arm for prophylactic vaccination.  On an unknown date, unknown latency, the patient developed itching at Flublok injection site (Injection site pruritus).  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  Outcome was reported as unknown for the event of injection site pruritus.
Approximately 30 minutes post vax, the pt developed a metallic taste in her mouth, a generalized red, flat rash, and edema of throat with difficulty swallowing. The pt was seen by a physician. The pt took Benadryl and was given Medrol dose pak and an injection of cortisone.
very bad headache; body aches; lump under left arm; Nauseous; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Apr2022 at 11:30 as dose 4 (booster), single (Lot number: FL3197) at the age of 59 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Chronic lymphocytic leukaemia" (unspecified if ongoing). Concomitant medication(s) included: VIT C. Vaccination history included: Covid-19 vaccine (Dose 1, Unknown Manufacturer), for Covid-19 Immunization; Covid-19 vaccine (Dose 2, Unknown Manufacturer), for Covid-19 Immunization; Covid-19 vaccine (Dose 3 (BOOSTER), Unknown Manufacturer), for Covid-19 Immunization. The following information was reported: NAUSEA (non-serious) with onset 26Apr2022 at 18:00, outcome "recovering", described as "Nauseous"; PAIN (non-serious) with onset 26Apr2022 at 18:00, outcome "recovering", described as "body aches"; LIMB MASS (non-serious) with onset 26Apr2022 at 18:00, outcome "recovering", described as "lump under left arm"; HEADACHE (non-serious) with onset 26Apr2022 at 18:00, outcome "recovering", described as "very bad headache". Therapeutic measures were not taken as a result of headache, pain, limb mass, nausea.  No follow-up attempts are needed. No further information is expected.
Patient initally experienced numbness and tingling in his throat and face. Advanced to left-side facial paralysis within one day. Cannot blink left eye or move lips on left side. Patient was put on Acyclovir, but still had the left-sided facial paralysis on 12/20/09 when I last spoke to the patient.
This spontaneous report as received from a registered nurse refers to unknown patients of unknown age and gender. Concurrent conditions and medical history were not reported. On an unknown date, the patients were vaccinated with an improperly stored doses of VARIVAX (Lot # M007287, 12-FEB-2018; M020899, 24-APR-2018; M024683 18-MAY-2018) (Dose and route were not provided). Concomitant medications were not reported. The temperature excursion details were -11.2 C for 1 hour 18 minutes. On lot # M007287, 12-FEB-2018) had an additional excursion of -9 degree C for 2 hours. A second freezer containing different lots of VARIVAX (M006726, 08-FEB-2018; M004328, 26-JAN-2018; L043622, 03-NOV-2017; M024683, 30-SEP-2018) with a temperature excursion of -12.9 degree C for 48 minutes. No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
the vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 20-Apr-2022; the vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 20-Apr-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (the vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 20-Apr-2022) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 20-Apr-2022) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 084J21A, 024M20A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (the vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 20-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 20-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (the vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 20-Apr-2022) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 20-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. The vial was initially stored in the refrigerator on 11-Jan-2022. The vial did not undergo any temperature excursions. No treatment medication was reported.
Localized swelling, redness and itching.  Counseled patient to apply cold compress, apply topical hydrocortisone or Benadryl and if situation worsened take oral Benadryl.
Fever of up to 104 for 3 days; local swelling; pain at injection site.
recently got covid; recently got covid; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team, Program ID: (004756).  A 13-month-old patient received BNT162b2 (BNT162B2), as dose number unknown , single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "recently got covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Drug ineffective depends on many factors including pharmacokinetics, severity of disease and patient general health condition. However on conservative basis, the possible causality cannot be excluded.
INFLAMMED RAISED RED CIRCLE SURROUNDING VACCINATION AREA; PT SAYS IT BURNS AND ITCHES, IS WARM TO THE TOUCH.
Information regarding Prevenar (pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) injection) was received from a healthcare professional regarding an unspecified number of patients who experienced extremely high fevers. The patients received doses on unspecified dates. Relevant medical history was not provided. Indication for Prevnar was not provided. product was administered on an unspecified date. Dose regimen was not provided. Additional suspect medication included Polio vaccine (poliomyelitis vaccine inactivated). Concomitant medications were nor reported. An unspecified number of patients experienced extremely high fevers (hyperpyrexia) after receiving both the Prevnar vaccine and Poli vaccine at the same time. No additional information was available at the time of this report. The reporter was unable to specify the number if patients who experienced this event. Additional reports will be generated when identifying information is provided.
little fever with a temperature of 99.1F; not feeling good; pulse rate of 97 that she feels is a little high; This is a spontaneous report from a contactable consumer.   A 63-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/ Lot number was not reported), via an unspecified route of administration on 11Aug2021, as a dose 2, single for COVID-19 immunisation. The patient medical history included COVID-19 (on an unspecified date in Apr2021 to unknown if ongoing). She had COVID on Apr20201 treated with monoclonal antibodies. Historical vaccination included that the patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date as a dose 1, single for COVID-19 immunization. The patient concomitant medications were not reported. On 12Aug2021 (Today, on the day of this report), the patient experienced little fever with a temperature of 99.1 F, not feeling good and pulse rate of 97 that she feels is a little high. She felt like she had COVID again. All the events were non-serious. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected. Information on lot number/batch number has been requested.
Within 5-10 minutes injection, tingling back of throat and increased mucus that lasted less than a minute; Within 5-10 minutes injection, tingling back of throat and increased mucus that lasted less than a minute; This is a spontaneous report from a contactable physician (patient). A 44-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: El0140, expiry date: unknown), intramuscular on 23Dec2020 18:00 at single dose (left arm) for COVID-19 immunization. Medical history included hypertension and allergies to medications, food, or other products: Shellfish, phenergan, possibly sulfa. Patient was not pregnant at the time of vaccination. Concomitant medication included melatonin, amlodipine, fluticasone propionate (FLONASE); medications the patient received within 2 weeks of vaccination. Facility where the most recent COVID-19 vaccine was administered was reported as Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that the patient, within 5-10 minutes injection, had tingling back of throat and increased mucus that lasted less than a minute on 23Dec2020 18:15. The outcome of the events was recovered on an unspecified date. Treatment was not received for the adverse event. Patient received second dose of bnt162b2 (lot number El3248) intramuscular on 14Jan2021 17:00 (vaccine location: Left arm). Events were reported as non-serious.
Nearly all of the symptoms listed on paperwork for the vaccine  Could also be allergic reaction to Septr antibiotic  but I don't know!
Patient was given the Hep B vaccine and later had a sore throat that evening. the following day also had difficulty swallowing. Saturday began having extreme irritability/mood swings. 2 days after immunization (sunday) began having hives on ankles and feet and itching. Following the previous hep B vaccination (8 weeks prior) Patient started stuttering which has happened after some other immunizations as well. He's still stuttering. Treated hives and throat with Benadryl. No doctor was consulted.
- Left ear ringing  - Left ear sense of loss of hearing ( very noticeable) - Left ear blocked feeling  - Right ear blocked feeling  - Right ear  sense loff of hearing ( relatively less compared to left ear)
Patient said at time of vaccination it hurt more than flu vaccine. Then checked her arm the next day where it was very red and swollen. Photo taken and sent per patient shows red bump and possible clotting near the bump. Down closer to her elbow.
Edema & erythema at site of injection, L/thigh. Scattered urticaria.
Pt recvd vax 3SEP92 & 5SEP92 exp achiness & listlessness; 6SEP92 devel a terrible neck ache, swelling on lt side of neck down into shoulder, redness & swelling @ the inject site, arm was swollen; seen by MD;
syncope and vomiting about 3 minutes post vaccination - applied wet paper towel and instant cold compress to forehead area and reassured patient - complete recovery by patient after about 10 minutes
Severe headache, chills and fever, muscles aches, muscle spasms.  Headache, chills and fever lasted until about 5am 4/2/2021.  Muscle spasms lasted until about noon on 4/2/2021 and muscle aches lasted until about 7am 4/3/2021.  Took Tylenol which didn't affect symptoms until the second dose.
diarrhea; tired; headache; chills; This is a spontaneous report from a contactable other HCP (patient). A 51-year-old female patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0142), via an unspecified route of administration in left arm on 16Jan2021 at single dose for COVID-19 immunisation. Medical history included ongoing Diabetes, Type 2 (Caller was diagnosed with this about 10 to 15 years ago), patient states that she has noticed that her blood sugars have gone up a bit. Patient states that she thinks that her sugars are up just because of stress on the body, because she had cancer and when she was going through her cancer, her sugars were all out of whack.  Patient states that any time her body is stressed her sugars will go up. There were no concomitant medications.  Patient states that she got the COVID Vaccine on Saturday 16Jan2021, and since then on 17Jan2021, she has been really tired, has a headache, and has chills; but caller states that all that is normal side effects that she read about. Caller states that the side effect she is concerned about is diarrhea, and she is wondering if that is a known side effect of the product. Caller received the vaccine on Saturday 16Jan2021, and her symptoms all started the next day on 17Jan2021. Caller confirms all symptoms are still ongoing but they have all improved. Caller confirms that she received no other vaccines on the same day as the COVID vaccine.  The outcome of the events was recovering.
Received expired dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired dose) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired dose). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.
Severe Headache Fever Chills Severe Nausea Vomiting and Diarrhea Fatigue Joint/Muscle Aches
Swollen arm; achy legs/sore arm; elevated temperature; sore injection site; flu like symptoms; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 68-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   Concurrent medical conditions included heartburn and migraine. Concomitant products included sumatriptan succinate and pantoprazole sodium.   On 24-OCT-2023, the patient received Arexvy .5 ml. On 25-OCT-2023, 1 days after receiving Arexvy, the patient experienced injection site pain (Verbatim: sore injection site), influenza-like symptoms (Verbatim: flu like symptoms), leg pain (Verbatim: achy legs/sore arm) and body temperature increased (Verbatim: elevated temperature). On 28-OCT-2023, the patient experienced swelling arm (Verbatim: Swollen arm). The patient was treated with cetirizine hydrochloride (Zyrtec). On 26-OCT-2023, the outcome of the influenza-like symptoms was not resolved. The outcome of the injection site pain, swelling arm, leg pain and body temperature increased were not resolved.   It was unknown if the reporter considered the injection site pain, influenza-like symptoms, swelling arm, leg pain and body temperature increased to be related to Arexvy.     It was unknown if the company considered the injection site pain, influenza-like symptoms, swelling arm, leg pain and body temperature increased to be related to Arexvy.   Additional Information: GSK Receipt Date: 29-OCT-2023 and 31-OCT-2023 The patient took Pantoprazole sodium delayed-release (DR) tablets daily. The patient received 120 mcg/0.5ml Arexvy injection. The patient had swollen sore arm and elevated temperature. The patient experienced flu like symptoms, achy legs, arms and sore injection site. Time to onset of swelling arm was 4 day. The consumer also stated that one doctor recommended that she initiate medication therapy with Zyrtec, however, she only took two doses of Zyrtec because the medication made her feel loopy. The symptoms were treated. The reporter consented to follow-up.
Very tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Very tired) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, the patient experienced FATIGUE (Very tired).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to MOD-2021-073234 (Patient Link).   Reporter did not allow further contact
16JAN91 pt vax w/ hepta B; exp trigeminal paresthesia left cheek roof of mouth. Recv CAT scan & MRI.
After my 2nd shot, I started to have neurological problems, including terrible muscle weakness. As it turns out, I have been diagnosed with Myasthenia Gravis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Unknown Manufacturer), for Covid-19 immunization. The following information was reported: MYASTHENIA GRAVIS (disability, medically significant), outcome "unknown", described as "After my 2nd shot, I started to have neurological problems, including terrible muscle weakness. As it turns out, I have been diagnosed with Myasthenia Gravis".  Clinical course: The patient stated that upon reading an article about how our profits drastically increased, the patient has written on how the profitable Covid vaccine affected the patient's life. After the 2nd shot, the patient started to have neurological problems, including terrible muscle weakness. As it turned out, the patient has been diagnosed with Myasthenia Gravis, an incurable autoimmune disease. The patient's doctors could not prove it was the vaccine. The patient stated that he/she never had any problems like this before it. The patient was terminated from his/her 22 year job and was trying to get disability.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Swelling of the lymph nodes; This is a spontaneous report from a contactable consumer.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), at SINGLE DOSE for covid-19 immunisation .  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient experienced swelling of the lymph nodes on an unspecified date with outcome of unknown.    Information about batch/lot number has been requested.